Nicolás Roche

41.2k total citations · 3 hit papers
543 papers, 14.0k citations indexed

About

Nicolás Roche is a scholar working on Pulmonary and Respiratory Medicine, Physiology and Neurology. According to data from OpenAlex, Nicolás Roche has authored 543 papers receiving a total of 14.0k indexed citations (citations by other indexed papers that have themselves been cited), including 333 papers in Pulmonary and Respiratory Medicine, 200 papers in Physiology and 56 papers in Neurology. Recurrent topics in Nicolás Roche's work include Chronic Obstructive Pulmonary Disease (COPD) Research (224 papers), Asthma and respiratory diseases (183 papers) and Respiratory and Cough-Related Research (86 papers). Nicolás Roche is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (224 papers), Asthma and respiratory diseases (183 papers) and Respiratory and Cough-Related Research (86 papers). Nicolás Roche collaborates with scholars based in France, United Kingdom and United States. Nicolás Roche's co-authors include Violaine Giraud, David Price, Didier Pradon, Pierre‐Régis Burgel, T. Pérez, Djamel Bensmaïl, Pascal Chanez, Gérard Huchon, Raphaël Zory and Claus Vogelmeier and has published in prestigious journals such as New England Journal of Medicine, The Lancet and Journal of Clinical Oncology.

In The Last Decade

Nicolás Roche

499 papers receiving 13.6k citations

Hit Papers

align trajectories

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Indacaterol–Glycopyrronium versus Salmeterol–Fluticasone for COPD

2016 547 citations Nicolás Roche, Claus Vogelmeier et al. profile →
Extrafine inhaled triple therapy versus dual bronchodilator therapy in chronic obstructive pulmonary disease (TRIBUTE): a double-blind, parallel group, randomised controlled trial

2018 398 citations Alberto Papi, Leonardo M. Fabbri et al. profile →
Mepolizumab to Prevent Exacerbations of COPD with an Eosinophilic Phenotype

2025 22 citations Gerard J. Criner, Alberto Papi et al. profile →

Peers

Countries citing papers authored by Nicolás Roche

Since Specialization

Citations

This map shows the geographic impact of Nicolás Roche's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Nicolás Roche with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Nicolás Roche more than expected).

Fields of papers citing papers by Nicolás Roche

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Nicolás Roche. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Nicolás Roche. The network helps show where Nicolás Roche may publish in the future.

Co-authorship network of co-authors of Nicolás Roche

This figure shows the co-authorship network connecting the top 25 collaborators of Nicolás Roche. A scholar is included among the top collaborators of Nicolás Roche based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Nicolás Roche. Nicolás Roche is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work	Indexed citations
1	Quelle connaissance et quelle perception ont les professionnels de santé d’un Centre de lutte contre le cancer à propos des pratiques palliatives encadrées par la loi Claeys-Leonetti : étude PAL PRAT 2024 ·Bulletin du Cancer ·(unknown), Cécile Flahault, Nicolás Roche, Christine Mateus, François Blot, (unknown), (unknown), Léonor Fasse	0
2	Influenza and pneumococcal vaccination in patients with COPD from 3 French cohorts: Insufficient coverage and associated factors 2024 ·Respiratory Medicine and Research ·Chantal Rahérison, B. Aguilaniu, M. Zysman, Pierre‐Régis Burgel, David A. Hess, (unknown), T.C.K. Tran, Nicolás Roche	0
3	Next-Gen GWAS: full 2D epistatic interaction maps retrieve part of missing heritability and improve phenotypic prediction 2024 ·Genome biology ·Clément Carré, (unknown), (unknown), (unknown), Nicolás Roche, Eric Hosy, André Mas, Gabriel Krouk	6
4	Baseline Characteristics and Maintenance Therapy Choice on Symptom Control, Reliever Use, Exacerbation Risk in Moderate–Severe Asthma: A Clinical Modelling and Simulation Study 2024 ·Advances in Therapy ·Pierluigi Paggiaro, Gabriel García, Nicolás Roche, Manish Verma, Maximilian Plank, (unknown), Janna K. Duong, (unknown), Oscar Della Pasqua	0
5	Chronic occupational exposures to irritants and asthma in the CONSTANCES cohort 2024 ·Occupational and Environmental Medicine ·(unknown), Laurent Orsi, Yuriko Iwatsubo, Brigitte Dananché, (unknown), Marcel Goldberg, Bénédicte Leynaert, Rachel Nadif, Céline Ribet, Nicolás Roche, Yves Roquelaure, Raphaëlle Varraso, Marie Zins, Corinne Pilorget, Nicole Le Moual, Orianne Dumas	6
6	Utilisation en vie réelle d’une triple thérapie fixe dans la BPCO : étude Trilife. Triple association fixe béclometasone/formotérol/glycopyrronium en particules extra-fines 2024 ·Revue des Maladies Respiratoires ·Nicolás Roche, (unknown), D Piperno, (unknown), (unknown), Audrey Lardy-Cléaud, (unknown), (unknown), P. Devillier	0
7	Patient and Provider Perspectives Driving Inhaler Choice 2024 ·CHEST Journal ·(unknown), Sinthia Bosnic‐Anticevich, Nicolás Roche, Omar S. Usmani	3
8	P237 Technophobia is not the most significant patient-reported barrier to accepting a digital adherence package: an analysis of the MAGNIFY trial 2023 ·(unknown), DMG Halpin, (unknown), (unknown), (unknown), John Chalmers, (unknown), (unknown), Alan Kaplan, (unknown), (unknown), Nicolás Roche, Omar S. Usmani, (unknown), (unknown), Karen Mezzi, (unknown), (unknown), David Price	1
9	A network meta-analysis of the association between patient traits and response to regular dosing with ICS/long-acting β2-agonist plus short-acting β2 agonist reliever or maintenance and reliever therapy for asthma 2023 ·Respiratory Medicine ·Arzu Yorgancıoğlu, Álvaro A. Cruz, Gabriel García, Kim Lavoie, Nicolás Roche, (unknown), Manish Verma, (unknown), (unknown)	0
10	Determinants of mouldy area size in dwellings from the French CONSTANCES population-based cohort 2023 ·Building and Environment ·(unknown), Émilie Fréalle, (unknown), Orianne Dumas, Marcel Goldberg, Nicole Le Moual, Céline Ribet, Nicolás Roche, Marine Savouré, Marie Zins, Bénédicte Leynaert, Laurent Orsi, Rachel Nadif	2
11	Air pollution and COPD: GOLD 2023 committee report 2023 ·European Respiratory Journal ·Don D. Sin, Dany Doiron, Àlvar Agustí, Antonio Anzueto, Peter J. Barnes, Bartolomé R. Celli, Gerard J. Criner, David Halpin, MeiLan K. Han, Fernando J. Martínez, María Montes de, Alberto Papi, Ian Pavord, Nicolás Roche, Dave Singh, Robert A. Stockley, (unknown), Jadwiga A. Wedzicha, Claus Vogelmeier, Jean Bourbeau	75
12	Household use of green and homemade cleaning products, wipe application mode, and asthma among French adults from the CONSTANCES cohort 2022 ·Indoor Air ·(unknown), (unknown), Marcel Goldberg, Bénédicte Leynaert, Rachel Nadif, Céline Ribet, Nicolás Roche, Marie Zins, Raphaëlle Varraso, Orianne Dumas, Nicole Le Moual	11
13	Interclass Difference in Pneumonia Risk in COPD Patients Initiating Fixed Dose Inhaled Treatment Containing Extrafine Particle Beclometasone versus Fine Particle Fluticasone 2022 ·SHILAP Revista de lepidopterología ·David Price, William Henley, José Eduardo Delfini Cançado, Leonardo M. Fabbri, Huib A.M. Kerstjens, Alberto Papi, Nicolás Roche, Elif Şen, Dave Singh, Claus Vogelmeier, (unknown), (unknown), Victoria Carter, Derek Skinner, Rebecca Vella, George Georges	6
14	Improving upper-limb and trunk kinematics by interactive gaming in individuals with chronic stroke: A single-blinded RCT 2022 ·Annals of Physical and Rehabilitation Medicine ·Maxime Térémetz, (unknown), Sylvain Hanneton, Agnès Roby-Brami, Nicolás Roche, Djamel Bensmaïl, Påvel G. Lindberg, Johanna V. G. Robertson	9
15	Maximizing Adherence and Gaining New Information For Your Chronic Obstructive Pulmonary Disease (MAGNIFY COPD): Study Protocol for the Pragmatic, Cluster Randomized Trial Evaluating the Impact of Dual Bronchodilator with Add-On Sensor and Electronic Monitoring on Clinical Outcomes 2021 ·PubMed ·David Price, Rupert Jones, Pascal Pfister, Hui Cao, Victoria Carter, Anu Kemppinen, Björn Holzhauer, Alan Kaplan, Allan Clark, David Halpin, Hilary Pinnock, James D. Chalmers, Job F. M. van Boven, Kai Michael Beeh, Κonstantinos Κostikas, Nicolás Roche, Omar S. Usmani, (unknown)	9
16	A scintigraphy study of budesonide/glycopyrrolate/formoterol fumarate metered dose inhaler in patients with moderate-to-very severe chronic obstructive pulmonary disease 2021 ·Respiratory Research ·Omar S. Usmani, Nicolás Roche, (unknown), Samuel Israel, Martin Jenkins, Roopa Trivedi, Paul Dorinsky, Magnus Aurivillius	11
17	Consistent Pulmonary Drug Delivery with Whole Lung Deposition Using the Aerosphere Inhaler: A Review of the Evidence 2021 ·International Journal of COPD ·Omar S. Usmani, Nicolás Roche, Martin Jenkins, Neda Stjepanovic, Peter Mack, Wilfried De Backer	28
18	In Patients with Mild-to-Moderate COPD, Tobacco Smoking, and Not COPD, Is Associated with a Higher Risk of Cardiovascular Comorbidity 2020 ·SHILAP Revista de lepidopterología ·Thibaud Soumagne, Alicia Guillien, Nicolás Roche, Isabella Annesi‐Maesano, Pascal Andujar, Lucie Laurent, S. Jouneau, (unknown), (unknown), (unknown), Bruno Degano	1
19	A review of national guidelines for management of COPD in Europe 2016 ·European Respiratory Journal ·Marc Miravitlles, Claus Vogelmeier, Nicolás Roche, David Halpin, João Cardoso, А. Г. Чучалин, Hannu Kankaanranta, Thomas Sandström, Paweł Śliwiński, Jaromír Zatloukal, Francesco Blasi	147
20	ERS Task Force Report. Guidelines for management of adult community-acquired lower respiratory tract infections. European Respiratory Society 1998 ·European Respiratory Journal ·Gérard Huchon, M. Woodhead, G Gialdroni-Grassi, P Léophonte, F. Manresa, T. Schaberg, Alejandro Torres, A. Didier, Jordi Dorca, (unknown), Nicolás Roche	167

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact